Huntington ' s disease : who decides ? Selection for presymptomatic testing for

نویسنده

  • ALAN FRYER
چکیده

I was interested to read the report of Goodship et al (J Med Genet 1995;32:746-8) of monozygotic (MZ) twins with a 22ql deletion who were discordant for cardiac defects. I have recently met a similar family where all the affected members have had a 22ql deletion detected by FISH. Twin 1 has a typical facial appearance of the velocardiofacial syndrome (figure) with nasal speech but no cardiac defect detectable clinically or on ECG. Twin 2 required a pharyngoplasty for nasopharyngeal insufficiency and had surgery for anASD during childhood. She has a very similar facies and both had mild learning difficulties during childhood.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Heterotaxia syndromes and 22q11 deletion.

1 Binedell J, Soldan JR, Harper PS. Selection for presymptomatic testing for Huntington's disease: who decides? J Med Genet 1996;33:1734. 2 World Federation of Neurology: Research Committee Research Group. Ethical issues policy statement on Huntington's disease molecular genetics predictive test. J Neurol Sci 1989;94: 327-32. 3 Clinical practice in medical genetics. Guidelines for the molecular...

متن کامل

The presymptomatic phase of Huntington disease.

Huntington disease is a neurodegenerative disorder transmitted as an autosomal dominant trait. It is the first neurological disease for which presymptomatic testing has been available for 20years in France. Follow-up of mutation carriers provided a better understanding of the presymptomatic phase of the disease and will change medical practice. Studying this phase led to the identification of c...

متن کامل

At-risk persons' attitudes toward presymptomatic and prenatal testing of Huntington disease in Michigan.

One hundred fifty-five individuals at 50% risk of inheriting Huntington disease (HD) were given a questionnaire surveying their sociodemographic characteristics, experience with HD, and attitudes toward presymptomatic and prenatal testing in HD. About two-thirds (63.2%) of the persons indicated they would take a presymptomatic test even if no specific treatment was available. Although one-half ...

متن کامل

Ethical considerations in presymptomatic testing for variant CJD.

Variant Creutzfeldt-Jakob disease (vCJD) is a fatal, transmissible, neurodegenerative disorder for which there is currently no effective treatment. vCJD arose from the zoonotic spread of bovine spongiform encephalopathy. There is now compelling evidence for human to human transmission through blood transfusions from presymptomatic carriers and experts are warning that the real epidemic may be y...

متن کامل

Presymptomatic testing for Huntington's disease in the United Kingdom. The United Kingdom Huntington's Disease Prediction Consortium.

OBJECTIVE To evaluate the United Kingdom Huntington's disease presymptomatic testing programme. DESIGN Postal questionnaire survey to collect data on all tests performed by clinical genetics centres between 1987 and 1990. SETTING Genetic centres providing presymptomatic testing in the United Kingdom. SUBJECTS 248 subjects at risk of Huntington's disease who had presymptomatic testing at t...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2004